0001611793-20-000001.txt : 20201030 0001611793-20-000001.hdr.sgml : 20201030 20201030134923 ACCESSION NUMBER: 0001611793-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201030 DATE AS OF CHANGE: 20201030 EFFECTIVENESS DATE: 20201030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONL Therapeutics, Inc. CENTRAL INDEX KEY: 0001611793 IRS NUMBER: 464627845 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-379321 FILM NUMBER: 201276548 BUSINESS ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: BUILDING 520, SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 BUSINESS PHONE: 734-926-5530 MAIL ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: BUILDING 520, SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 D 1 primary_doc.xml X0708 D LIVE 0001611793 ONL Therapeutics, Inc. 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 734-926-5530 DELAWARE None None Corporation true David Zacks 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Executive Officer Director Mark Hooper 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director Christine Gibbons 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director Felicia David-Visser 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director David Esposito 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Executive Officer Director Biotechnology Decline to Disclose 06b false 2020-10-19 false true false 0 2000000 2000000 0 false 3 0 0 0 false ONL Therapeutics, Inc. David Esposito David Esposito CEO & President 2020-10-30